Arrowstreet Capital, Limited Partnership Harmony Biosciences Holdings, Inc. Transaction History
Arrowstreet Capital, Limited Partnership
- $121 Billion
- Q3 2024
A detailed history of Arrowstreet Capital, Limited Partnership transactions in Harmony Biosciences Holdings, Inc. stock. As of the latest transaction made, Arrowstreet Capital, Limited Partnership holds 317,566 shares of HRMY stock, worth $11.2 Million. This represents 0.01% of its overall portfolio holdings.
Number of Shares
317,566Holding current value
$11.2 Million% of portfolio
0.01%Shares
3 transactions
Others Institutions Holding HRMY
# of Institutions
243Shares Held
45.2MCall Options Held
108KPut Options Held
49.2K-
Valor Management LLC Chicago, IL11.2MShares$394 Million100.0% of portfolio
-
Black Rock Inc. New York, NY5.84MShares$205 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA3.47MShares$122 Million0.0% of portfolio
-
Vivo Capital, LLC Palo Alto, CA2.61MShares$91.6 Million15.24% of portfolio
-
Pacer Advisors, Inc. Malvern, PA1.93MShares$67.7 Million0.18% of portfolio
About Harmony Biosciences Holdings, Inc.
- Ticker HRMY
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 59,161,400
- Market Cap $2.08B
- Description
- Harmony Biosciences Holdings, Inc., a commercial-stage pharmaceutical company, develops and commercializes therapies for patients with rare neurological disorders in the United States. Its product, WAKIX is a medication for the treatment of excessive daytime sleepiness in adult patients with narcolepsy. The company was formerly known as Harmony ...